Neurogenic overactive bladder (OAB) is a chronic and distressing medical condition that has profound physical, emotional, and financial ramifications for patients and is commonly seen in patients with ...
A COMMON bladder infection could increase the risk of dementia by a fifth, scientists suggest. Cystitis, a urinary tract ...
MRI-based assessment shortened the time to correct treatment, when compared with TURBT, for patients with MIBC. MRI-based assessment may eliminate the need for transurethral resection of bladder tumor ...
Appropriate management relies on an accurate diagnosis. In some patients with NGB, the original cause of their symptoms may be misdiagnosed, resulting in failure of initial therapy. 9 Assessment ...
Abdominal injuries have high associated mortality, making early diagnosis and timely treatment essential. Traditionally, radiographic investigation for bladder injury has followed detection of ...
In a small but multi-institutional study, an artificial intelligence-based system improved providers' assessments of whether patients with bladder cancer had complete response to chemotherapy before a ...
Artificial intelligence helps physicians better assess the effectiveness of bladder cancer treatment
In a small but multi-institutional study, an artificial intelligence-based system improved providers' assessments of whether patients with bladder cancer had complete response to chemotherapy before a ...
Clinical efficacy of enfortumab vedotin-pembrolizumab (EV-P) in locally advanced (LA) or metastatic urothelial carcinoma (mUC): A real-world retrospective study. This is an ASCO Meeting Abstract from ...
Clinicopathological characterization, FGFR alteration prevalence, and outcomes of locally advanced or metastatic urothelial cancer in Latin America (LACOG 1518). Crosstalk among T-cell CX3CR1, immune ...
—An analysis of long-term bladder cancer survivors finds that high levels of physical activity improve self-reported health-related quality of life. New data from a large cohort of bladder cancer ...
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results